Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca

References

• Sjogren H, Block KJ. Keratoconjunctivitis sicca and the Sjögren' s syndrome. Surv Ophthalmol. 1971;16:145–59.
   Google Scholar
• Pflugfelder SC, Tseng SCG, Sanabria 0, Kell H, Garcia CG, Felix C, Feuer W, Reis BL. Evaluation of subjec-tive assessments and objective diagnostic tests for diag-nosing tear-film disorders known to cause ocular irrita-tion. Cornea. 1998;17:38–56.
   Google Scholar
• Pflugfelder SC, Tseng SCG, Yoshino K, Monroy D, Felix C, Reis B. Correlation of goblet cell density and mu-cosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Oph-thalmology. 1997;104:223–35.
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Huang AJW, Feuer W, Chuchovski PT, Pereira I, Tseng SCG. Conjunctival cytologic features of primary Sjögren's syndrome. Ophthalmology. 1990;97: 985–991.
   PubMed Web of Science ®Google Scholar
• Tseng SCG. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology. 1985;92:728–33.
   PubMed Web of Science ®Google Scholar
• Danjo Y. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol. 1994;72:433–7.
   PubMed Web of Science ®Google Scholar
• Gilbard JP, Farris RL, Santamaria IJ. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol. 1978;96:677–81.
   PubMed Web of Science ®Google Scholar
• Goren MB, Goren SB. Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol. 1988;106:570–4.
   PubMed Web of Science ®Google Scholar
• Janssen PT, van Bijsterveld OP. Tear fluid proteins in Sjögren's syndrome. Scand J Rheumatol Suppl. 1986;61:224–7.
   PubMedGoogle Scholar
• Mackie IA, Seal DV. Diagnostic implications of tear protein profiles. Br J Ophthalmol. 1984;68:321–4.
   PubMed Web of Science ®Google Scholar
• McCollum CJ, Foulks GN, Bodner B, Shepard J, Daniels K, Cross V, Kelly L, Cavanagh HD. Rapid assay of lactoferrin in keratoconjunctivitis sicca. Cornea. 1994; 13:505–8.
   PubMed Web of Science ®Google Scholar
• Van Setten GB. Epidermal growth factor in human tear fluid: increased release but decreased concentration during reflex tearing. Current Eye Res. 1990;9:79–83.
   PubMed Web of Science ®Google Scholar
• Yoshino K, Monroy D, Pflugfelder SC. Cholinergic stimu-lation of lactoferrin and epidermal growth factor secre-tion by the human lacrimal gland. Cornea. 1996;15: 617–621.
   Google Scholar
• Carraway KU, Cantley LC. A neu acquaintance of ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling. Cell. 1994;78:5–8.
   PubMed Web of Science ®Google Scholar
• Carraway KL, Carothers Carraway CA, Carraway KLI. Roles of ErbB-3 and ErbB-4 in the physiology and pa-thology of the mammary gland. J Mammary Gland Biol Neoplasia. 1997;2:187–97.
   PubMed Web of Science ®Google Scholar
• Nava A, Barton K, Monroy D, Pflugfelder SC. The ef- fects] of age, gender, and fluid dynamics on the concen-tration of tear film epidermal growth factor. Cornea. 1997;16:430–438.
   PubMed Web of Science ®Google Scholar
• Van Setten, GB, Viinikka L, Tervo T. Epidermal growth factor is a constant component of normal human tear fluid. Graefe's Arch Clin Exp Ophthalmol. 1989;22:184–187.
   Web of Science ®Google Scholar
• Van Setten GB. Ocular disease leads to decreased con-centrations of epidermal growth factor in the tear fluid. Curr Eye Res. 1991;10:523–7.
   PubMed Web of Science ®Google Scholar
• Hikichi T, Yoshida A, Tsubota K. Lymphocytic infiltra-tion of the conjunctiva and the salivary gland in Sjögren's syndrome. Arch Ophthalmol. 1993;111:21–2.
   Google Scholar
• Raphael M, Bellefgih S, Piette J Ch, Le Hoang Ph, Debre P, Chomette G. Conjunctival biopsy in Sj8gren's syn-drome: correlations between histologic and immunohis-tochemical features. Histopathology. 1988;13: 191–202.
   Google Scholar
• Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjögren's syndrome: cytokine and Epstein-Barr virus gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci. 1994;35:3493–3504.
   Google Scholar
• Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflamma-tion. Invest Ophthalmol Vis Sci. 1997;38:1458–64.
   Google Scholar
• Zsubota K. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica. 1999;213:16–9.
   PubMed Web of Science ®Google Scholar
• Yannopoulos DI, Roncin S, Lamour A, Pennec YL, Moutsopoulos HM, Youinou P. Conjunctival epithelial cells from patients with Sj8gren's syndrome inappropriate-ly express major histocompatability molecules. J Clin Immunol. 1992;51:259–65.
   Web of Science ®Google Scholar
• Markusse HM, Huysen JC, Nieuwenhuys EJ, Swaak AJ. Beta 2 microglobulin in tear fluid from patients with primary Sjögren's syndrome. Ann Rheum Dis. 1992;51: 503–5.
   PubMed Web of Science ®Google Scholar
• Tishler M, Yaron I, Geyer D, Shirazi I, Naftalier E, Yaron M]. Elevated tear interleukin-6 levels in patients with Sjögren's syndrome. Ophthalmology. 1998;105: 2327–9.
   Google Scholar
• Gunduz K, Ozdemir 0. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syn-drome. Acta Ophthalmol. 1994;72: 442
   Google Scholar
• Tabbara KF, Frayha RA. Alternate-day steroid therapy for patients with primary Sj8gren's syndrome. Ann Ophthalmol. 1983;15:358–61.
   PubMedGoogle Scholar
• Marsh P, Pflugfelder SC. Topical non-preserved meth-ylprednisolone therapy of keratoconjunctivitis sicca in Sjogren's syndrome. Ophthalmology. 1999; in press.
   Google Scholar
• Gillitzer R, Ritter U, Spandau U, Goebeler M, Brocker EB. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol. 1996;107: 778–82.
   Google Scholar
• Yoshinaga Y, Higaki M, Terajima S, Ohkubo E, Nogita,T. Miyasaka,N.; Kawashima,M.et al. Detection of inflam-matory cytokines in psoriatic skin. Arch Dermatol Res. 1995;287:158–64.
   Google Scholar
• Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb-Bachofen V. A proinflammatory activity of interleukin 8 in human skin: expression of the induc-ible nitric oxide synthase in psoriatic lesions and cul-tured keratinocytes. J Exp Med. 1996;184: 2007–12.
   Google Scholar
• Grossman RM, Kupper T, Yourish D, Piperno AG, Murphy DP, May LT, Sehgel PB, Gottlieb AB. Interleukin 6 is expressed in high levels in psoriatic skin and stimu-lates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA. 1989;86:6367–71.
   PubMed Web of Science ®Google Scholar
• Cooper KD. Psoriasis. Leukocytes and cytokines. Dermatol Clin. 1990;8:737–41.
   PubMed Web of Science ®Google Scholar
• McKenzie RC, Saunder DN. Keratinocyte cytokines and growth factors. Functions in skin immunity and homeo-stasis. Dermatol Clin. 1990;8:649–60.
   PubMed Web of Science ®Google Scholar
• de Jong EM, Ferrier CM, de Zwart A, Wauben-Penris PJ, Korstanje C, van de Kerkhof PC. Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis. J Dermatol Sci. 1995;9:185–94.
   Google Scholar
• Smith KJ, Skelton HG. Effects of cyclosporine on cytokines and cytokine receptors in psoriasis [letter; comment]. J Am Acad Dermatol. 1997;36:656–8.
   PubMed Web of Science ®Google Scholar
• Michel G, Auer H, Kemeny L, Bocking A, Ruzicka T. Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus (FK506). Biochem Pharmacol. 1996;51: 1315–20.
   Google Scholar
• Lemster BH, Carroll PB, Rib o HR, Johnson N, Nikaein A, Thomson AW. IL-8/IL-8 receptor expression in pso-riasis and the response to systemic tacrolimus (FK506) therapy. Clin Exp Immunol. 1995;99:148–54.
   PubMed Web of Science ®Google Scholar
• Fox RI, Robinson CA, Curd JG, Kozir F, Howell FV. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum. 1986;29:577–85.
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Tseng SCG, Pepose J, Fletcher MA, Klimas N, Feuer W. Epstein-Barr virus infection and im-munologic dysfunction in patients with aqueous tear deficiency. Ophthalmology. 1990;97:313–23.
   PubMed Web of Science ®Google Scholar
• Jones DT, Monroy D, Pflugfelder SC. A novel method of tear collection. Comparison of glass capillary tubes with porous polyester rods. Cornea. 1997;16:450–458.
   Google Scholar
• Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, ba-sic FGF, TGF-beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33: 1756–1765.
   Google Scholar
• Lausch RN, Chen SH, Tumpey TM, Su YH, Oakes JE. Early cytokine synthesis in the excised mouse cornea. J Interferon Cytokine Res. 1996;16:35–40.
   PubMed Web of Science ®Google Scholar
• Sakamoto S, Inada K, Chiba K, Yoshida M, Tazawa Y. Production of IL-6 and IL-1 alpha by human corneal epi-thelial cells. Nippon Ganka Gakkai Zasshi. 1991;95: 728–32.
   Google Scholar
• Souaze F, Ntodou-Thome A, Tran CY, Rostene W, Forgez P. Quantitative RT-PCR: limits and accuracy. BioTech-niques. 1996;21:280–5.
   PubMed Web of Science ®Google Scholar
• Sporn MB, Roberts AB. The Multifunctional Nature of Peptide] Growth Factors. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors I. New York: Springer-Verlag, 1990:3–15.
   Google Scholar
• Chrousos GP. The hypothalmic-pituitary adrenal axis and immune mediated inflammation. N Engl J Med. 1995;3 32:1351–61.
   Web of Science ®Google Scholar
• Warbrick EV, Thomas AL, Williams CM. The effects of cyclosporin A, dexamethasone and other immuno-modulatory drugs on induced expression of IL-3, IL-4 and IL-8 mRNA in a human mast cell line. Toxicology. 1997;116: 211–8.
   Google Scholar
• Gupta A, Monroy D, Ji Z, Yoshino K, Huang A, Pflug-felder SC. Transforming growth factor beta-1 and beta-2 in human tear fluid. Cur Eye Res. 1986;15: 605–614.
   Google Scholar
• Massaque J. The transforming growth factor-beta fam-ily. Annu Rev Cell Biol. 1990;68:597–641.
   Google Scholar
• Sporn MB, Roberts AB. Transforming growth factor-beta. Multiple actions and potential clinical applications. JAMA. 1989;262:938–41.
   Google Scholar